相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Distinct Subset of Glioma Cell Lines with Stem Cell-like Properties Reflects the Transcriptional Phenotype of Glioblastomas and Overexpresses CXCR4 as Therapeutic Target
Alexander Schulte et al.
GLIA (2011)
MGMT promoter hypermethylation is a frequent, early, and consistent event in astrocytoma progression, and not correlated with TP53 mutation
Floris H. Groenendijk et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
Effect of aberrant p53 function on temozolomide sensitivity of glioma cell lines and brain tumor initiating cells from glioblastoma
Michael D. Blough et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
The cancer stem cell: premises, promises and challenges
Hans Clevers
NATURE MEDICINE (2011)
Efficient delivery of liposome-mediated MGMT-siRNA reinforces the cytotoxity of temozolomide in GBM-initiating cells
T. Kato et al.
GENE THERAPY (2010)
Regulation of the p53 pathway by ubiquitin and related proteins
Andreas Hock et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2010)
O-6-Methylguanine DNA methyltransferase protein expression in tumor cells predicts outcome of temozolomide therapy in glioblastoma patients
Sabine Spiegl-Kreinecker et al.
NEURO-ONCOLOGY (2010)
Sensitivity to temozolomide in brain tumor initiating cells
Michael D. Blough et al.
NEURO-ONCOLOGY (2010)
Levetiracetam enhances p53-mediated MGMT inhibition and sensitizes glioblastoma cells to temozolomide
George C. Bobustuc et al.
NEURO-ONCOLOGY (2010)
Standard Therapy for Glioblastoma-A Review of Where We Are
Ryo Nishikawa
NEUROLOGIA MEDICO-CHIRURGICA (2010)
Crosstalk Between the PI3K/mTOR and MEK/ERK Pathways Involved in the Maintenance of Self-Renewal and Tumorigenicity of Glioblastoma Stem-Like Cells
Jun Sunayama et al.
STEM CELLS (2010)
Advances in the Treatment of Malignant Gliomas
Mustafa Khasraw et al.
CURRENT ONCOLOGY REPORTS (2010)
Temozolomide in malignant gliomas: current use and future targets
J. Lee Villano et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
Association Between MGMT Promoter Hypermethylation and p53 Mutation in Glioblastoma
Jamal Shamsara et al.
CANCER INVESTIGATION (2009)
Glioma Stem Cell Lines Expanded in Adherent Culture Have Tumor-Specific Phenotypes and Are Suitable for Chemical and Genetic Screens
Steven M. Pollard et al.
CELL STEM CELL (2009)
Autocrine TGF-β Signaling Maintains Tumorigenicity of Glioma-Initiating Cells through Sry-Related HMG-Box Factors
Hiroaki Ikushima et al.
CELL STEM CELL (2009)
Genomic and Expression Profiling of Glioblastoma Stem Cell-Like Spheroid Cultures Identifies Novel Tumor-Relevant Genes Associated with Survival
Aurelie Ernst et al.
CLINICAL CANCER RESEARCH (2009)
An efficient method for derivation and propagation of glioblastoma cell lines that conserves the molecular profile of their original tumours
Talal M. Fael Al-Mayhani et al.
JOURNAL OF NEUROSCIENCE METHODS (2009)
Small-Molecule Inhibitors of the MDM2-p53 Protein-Protein Interaction to Reactivate p53 Function: A Novel Approach for Cancer Therapy
Sanjeev Shangary et al.
Annual Review of Pharmacology and Toxicology (2008)
Temozolomide preferentially depletes cancer stem cells in glioblastoma
Dagmar Beier et al.
CANCER RESEARCH (2008)
Correlation of O6-Methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity
Monika E. Hegi et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
L. Chin et al.
NATURE (2008)
The activation of ERK1/2 MAP kinases in glioblastoma pathobiology and its relationship with EGFR amplification
Concha Lopez-Gines et al.
NEUROPATHOLOGY (2008)
Malignant gliomas in adults
Patrick Y. Wen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Local intracerebral administration of O6-benzylguanine combined with systemic chemotherapy with temozolomide of a patient suffering from a recurrent glioblastoma
Dorothee Koch et al.
JOURNAL OF NEURO-ONCOLOGY (2007)
Analysis of gene expression and chemoresistance of CDI33+ cancer stem cells in glioblastoma
Gentao Liu et al.
MOLECULAR CANCER (2006)
Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines
Jeongwu Lee et al.
CANCER CELL (2006)
O6-methylguanine DNA methyltransferase and p53 status predict temozolomide sensitivity in human malignant glioma cells
M Hermisson et al.
JOURNAL OF NEUROCHEMISTRY (2006)
MEK-ERK signaling controls Hdm2 oncoprotein expression by regulating hdm2 mRNA export to the cytoplasm
M Phelps et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Plasma and cerebrospinal fluid population pharmacokinetics of temozolomide in malignant glioma patients
S Ostermann et al.
CLINICAL CANCER RESEARCH (2004)
Opposing effects of Ras on p53:: Transcriptional activation of mdm2 and induction of p19ARF
S Ries et al.
CELL (2000)
分享论文
